Shree Ganesh Remedies Balance Sheet Annual

Trade

BSE: 540737 | NSE: - | ISIN: INE414Y01015 | Sector: Biotechnology & Drugs

690.00 +16.40 (2.43%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.41	2.50	-	-
Cash Equivalents	15.85	8.65	3.88	3.47
Short Term Investments	4.68	-	-	3.12
Cashand Short Term Investments	20.94	11.15	3.88	6.59
Accounts Receivable- Trade Net	20.33	27.92	18.38	13.33
Total Receivables Net	20.33	34.97	27.38	18.69
Total Inventory	24.99	18.18	13.64	12.71
Other Current Assets Total	3.94	-	-	-
Total Current Assets	70.20	64.29	44.91	37.99
Property/ Plant/ Equipment Total- Net	97.11	76.45	29.82	20.29
Intangibles Net	0.36	0.55	0.47	0.60
Long Term Investments	1.26	1.42	1.77	0.07
Other Long Term Assets Total	2.00	1.13	0.05	0.10
Total Assets	170.94	143.83	77.02	60.60
Accounts Payable	8.19	14.53	9.47	6.21
Notes Payable/ Short Term Debt	7.19	2.58	0.00	0.17
Current Portof LT Debt/ Capital Leases	0.01	-	-	-
Other Currentliabilities Total	3.29	6.63	5.57	3.81
Total Current Liabilities	18.68	23.74	15.04	10.19
Long Term Debt	29.12	30.93	0.00	-
Capital Lease Obligations	0.12	-	-	-
Total Long Term Debt	29.24	30.93	0.00	0.00
Total Debt	36.45	33.51	0.00	0.17
Deferred Income Tax	0.58	0.00	0.20	0.24
Other Liabilities Total	0.33	0.22	0.20	0.17
Total Liabilities	48.84	54.90	15.44	10.59
Common Stock Total	12.84	12.51	12.01	10.01
Retained Earnings( Accumulated Deficit)	109.25	76.56	49.72	40.15
Total Equity	122.10	88.94	61.57	50.00
Total Liabilities Shareholders' Equity	170.94	143.83	77.02	60.60
Total Common Shares Outstanding	1.28	1.20	1.26	1.05
Tangible Book Valueper Share Common Eq	94.75	73.62	48.53	47.07
Other Equity Total	-	-0.13	-0.16	-0.16
Note Receivable- Long Term	-	-	-	1.54